METODIKA SLEDOVÁNÍ STATICKÝCH A DYNAMICKÝCH PARAMTERŮ AKOMODACE U SUBJEKTŮ STUDIE M.A.R.S. LÉČENÝCH VYSOCE ŘEDĚNÝM ATROPINEM

Title in English METHODOLOGY FOR MONITORING STATIC AND DYNAMIC PARAMETERS OF ACCOMMODATION IN THE SUBJECTS OF THE M.A.R.S. STUDY. TREATED WITH HIGHLY DILUTE ATROPINE
Authors

ČÁSLAVSKÁ M. DOSTÁLEK Miroslav BORŮVKOVÁ M. JEŘÁBKOVÁ L. KOMÍNEK Martin HOZMAN J. BENEŠ Pavel AUTRATA Rudolf

Year of publication 2023
MU Faculty or unit

Faculty of Medicine

Citation
Description M.A.R.S. is ongoing, multicentre, randomized, double masked, placebo-controlled phase IIIb trial with three parallel arms. This is a paediatric clinical trial in which 288 children (6-12 years) with myopia (from -0.5 to -4, 75.0 dioptres) will be randomized in period from June 2022 till the end of October 2023. The primary outcome of the clinical evaluation is to determine the difference in the axial length of the eye (AXL) during the 12M application period when applying 0.02% atropine versus placebo.

You are running an old browser version. We recommend updating your browser to its latest version.

More info